Literature DB >> 9717522

Oncogene amplification and expression in pediatric solid tumors.

J Mares1, V Polanská, H Görgens, Z Sedlácek, T Maríková, P Bocek, R Kodet, J Schackert, P Goetz.   

Abstract

Oncogene amplification and expression and their mutual relationship was analyzed in 92 pediatric tumors by Southern and Northern blot hybridization with N-MYC, ERB A, ERB B, N-RAS and Shb probes. Amplification and overexpression was associated with more advanced clinical stages of tumor, especially in neuroblastomas, rhabdomyosarcomas and ganglioneuroblastomas. The most frequent alteration observed was N-MYC amplification together with overexpression. N-RAS amplification was not detected, while the overexpression of this oncogene was found in 3 cases. Neither amplification nor overexpression was revealed in any specimen of hepatoblastoma or hepatocellular carcinoma. We suggest that oncogenes overexpression provides more accurate prognostic information than amplification.

Entities:  

Mesh:

Year:  1998        PMID: 9717522

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  5 in total

1.  Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome.

Authors:  R G Weber; T Pietsch; D von Schweinitz; P Lichter
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Gene expression profiling of human hepatoblastoma using archived formalin-fixed and paraffin-embedded tissues.

Authors:  Eun Shin; Kyoung-Bun Lee; Soo-Young Park; Soo-Hee Kim; Han-Suk Ryu; Young-Nyun Park; Eunsil Yu; Ja-June Jang
Journal:  Virchows Arch       Date:  2011-03-03       Impact factor: 4.064

3.  Comparative genomic hybridization reveals population-based genetic alterations in hepatoblastomas.

Authors:  S G Gray; S Kytölä; T Matsunaga; C Larsson; T J Ekström
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

4.  Genotypic Characteristics of Hepatoblastoma as Detected by Next Generation Sequencing and Their Correlation With Clinical Efficacy.

Authors:  Huimin Hu; Weiling Zhang; Tian Zhi; Jing Li; Yuan Wen; Fan Li; Yanyan Mei; Dongsheng Huang
Journal:  Front Oncol       Date:  2021-08-06       Impact factor: 6.244

5.  Genomic copy number gains of ErbB family members predict poor clinical outcomes in glioma patients.

Authors:  Rui Liu; Yiping Qu; Lihong Chen; Jun Pu; Sharui Ma; Xiaozhi Zhang; Qi Yang; Bingyin Shi; Peng Hou; Meiju Ji
Journal:  Oncotarget       Date:  2017-09-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.